{"Return": {"ReturnHeader": {"PreparerFirm": {"PreparerFirmBusinessName": {"BusinessNameLine1": "BST ADVISORS LLC"}, "PreparerFirmUSAddress": {"AddressLine1": "26 COMPUTER DRIVE WEST", "City": "ALBANY", "State": "NY", "ZIPCode": "12205"}}, "Filer": {"Name": {"BusinessNameLine1": "ORDWAY RESEARCH INSTITUTE INC"}, "USAddress": {"AddressLine1": "150 NEW SCOTLAND AVE", "City": "ALBANY", "State": "NY", "ZIPCode": "12208"}, "EIN": "010682614", "NameControl": "ORDW", "Phone": "5186416410"}, "Officer": {"Name": "albert szesnat", "Title": "corporate secretary", "Phone": "5186416410", "DateSigned": "2011-05-02", "AuthorizeThirdParty": "1"}, "Preparer": {"Name": "RONALD L GUZIOR", "Phone": "5184596700"}, "Timestamp": "2011-05-12T12:58:24-05:00", "TaxPeriodEndDate": "2010-06-30", "ReturnType": "990", "TaxPeriodBeginDate": "2009-07-01", "TaxYear": "2009", "BuildTS": "2016-02-24 21:20:13Z"}, "ReturnData": {"IRS990": {"AddressPrincipalOfficerUS": {"AddressLine1": "150 NEW SCOTLAND AVE", "City": "ALBANY", "State": "NY", "ZIPCode": "12208"}, "Activity2": {"Expense": "1808490", "Description": "THE GOAL OF THE ORDWAY CANCER CENTER IS TO DEVELOP INNOVATIVE STRATEGIES FOR DESIGNING INDIVIDUALIZED CANCER THERAPY."}, "Activity3": {"Expense": "1507847", "Description": "INSTITUTE FOR CLINICAL PHARMACODYNAMICS: ICPD helpS pharmaceutical and biotechnology companies get safer and more effective drugs to patients through advanced methods of pharmacokinetic and pharmacodynamic system analysis."}, "ActivityOther": {"Expense": "676459", "Description": "MEDICAL RESEARCH CONDUCTED IN THE FIELD OF SIGNAL TRANSFER."}, "TheBooksAreInCareOf": {"NameBusiness": {"BusinessNameLine1": "ALBERT SZESNAT"}, "AddressUS": {"AddressLine1": "150 NEW SCOTLAND AVE", "City": "ALBANY", "State": "NY", "ZIPCode": "12208"}, "TelephoneNumber": "5186416410"}, "Form990PartVIISectionA": [{"NamePerson": "PAUL DAVIS MD", "Title": "DIRECTOR/BOARD MEMBER", "AverageHoursPerWeek": "40.00", "IndividualTrusteeOrDirector": "X", "Officer": "X", "ReportableCompFromOrganization": "293657", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "19640"}, {"NamePerson": "ALBERT SZESNAT", "Title": "CORPORATE SECRETARY", "AverageHoursPerWeek": "40.00", "IndividualTrusteeOrDirector": "X", "Officer": "X", "ReportableCompFromOrganization": "109816", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "8044"}, {"NamePerson": "VINCENT VERDILE MD", "Title": "CHAIRMAN", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "RICHARD LIEBICH", "Title": "TREASURER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "RObert desjardins md", "Title": "bOARD MEMBER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "CARMEL MANNELLA", "Title": "BOARD MEMBER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "LYNN VIDEKA ph d", "Title": "BOARD MEMBER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "c douglas webb ph d", "Title": "BOARD MEMBER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "CANDACE KING WEIR", "Title": "BOARD MEMBER", "AverageHoursPerWeek": "1.00", "IndividualTrusteeOrDirector": "X", "ReportableCompFromOrganization": "0", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "0"}, {"NamePerson": "GEORGE DRUSANO", "Title": "CO-DIRECTOR", "AverageHoursPerWeek": "40.00", "KeyEmployee": "X", "ReportableCompFromOrganization": "326618", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "17495"}, {"NamePerson": "IGOR RONINSON", "Title": "SR SCIENTIST", "AverageHoursPerWeek": "40.00", "HighestCompensatedEmployee": "X", "ReportableCompFromOrganization": "231886", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "22989"}, {"NamePerson": "ARNOLD LOUIE", "Title": "SR SCIENTIST", "AverageHoursPerWeek": "40.00", "HighestCompensatedEmployee": "X", "ReportableCompFromOrganization": "245719", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "15579"}, {"NamePerson": "paul ambrose", "Title": "SR SCIENTIST", "AverageHoursPerWeek": "40.00", "HighestCompensatedEmployee": "X", "ReportableCompFromOrganization": "187991", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "23081"}, {"NamePerson": "RAlph buttyan", "Title": "SR SCIENTIST", "AverageHoursPerWeek": "40.00", "HighestCompensatedEmployee": "X", "ReportableCompFromOrganization": "176845", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "16566"}, {"NamePerson": "SUJATA BHAVNANI", "Title": "SR SCIENTIST", "AverageHoursPerWeek": "40.00", "HighestCompensatedEmployee": "X", "ReportableCompFromOrganization": "150050", "ReportableCompFromRelatedOrgs": "0", "OtherCompensation": "20781"}], "ProgramServiceRevenue": {"Description": "program revenue", "BusinessCode": "541711", "TotalRevenueColumn": "642862", "RelatedOrExemptFunctionIncome": "642862"}, "InvestmentIncome": {"TotalRevenueColumn": "30467", "ExclusionAmount": "30467"}, "GrossAmountSalesAssets": {"Securities": "890749"}, "LessCostOthBasisSalesExpenses": {"Securities": "758761", "Other": "237490"}, "GainOrLoss": {"Securities": "131988", "Other": "-237490"}, "NetGainOrLossInvestments": {"TotalRevenueColumn": "-105502", "ExclusionAmount": "-105502"}, "TotalRevenue": {"TotalRevenueColumn": "13139995", "RelatedOrExemptFunctionIncome": "642862", "UnrelatedBusinessRevenue": "0", "ExclusionAmount": "-75035"}, "CompCurrentOfficersDirectors": {"Total": "1722582", "ProgramServices": "1175083", "ManagementAndGeneral": "547499"}, "OtherSalariesAndWages": {"Total": "4733844", "ProgramServices": "3229255", "ManagementAndGeneral": "1504589"}, "PensionPlanContributions": {"Total": "329821", "ProgramServices": "224992", "ManagementAndGeneral": "104829"}, "OtherEmployeeBenefits": {"Total": "625211", "ProgramServices": "426496", "ManagementAndGeneral": "198715"}, "PayrollTaxes": {"Total": "427758", "ProgramServices": "291801", "ManagementAndGeneral": "135957"}, "FeesForServicesLegal": {"Total": "91588", "ProgramServices": "5603", "ManagementAndGeneral": "85985"}, "FeesForServicesAccounting": {"Total": "29000", "ManagementAndGeneral": "29000"}, "OfficeExpenses": {"Total": "86318", "ProgramServices": "34943", "ManagementAndGeneral": "51375"}, "InformationTechnology": {"Total": "37733", "ProgramServices": "24172", "ManagementAndGeneral": "13561"}, "Occupancy": {"Total": "3646795", "ProgramServices": "22320", "ManagementAndGeneral": "3624475"}, "Travel": {"Total": "201812", "ProgramServices": "56819", "ManagementAndGeneral": "144993"}, "ConferencesMeetings": {"Total": "86040", "ProgramServices": "12167", "ManagementAndGeneral": "73873"}, "Interest": {"Total": "99026", "ManagementAndGeneral": "99026"}, "DepreciationDepletion": {"Total": "430700", "ManagementAndGeneral": "430700"}, "Insurance": {"Total": "86263", "ManagementAndGeneral": "86263"}, "OtherExpenses": [{"Description": "Research Materials", "Total": "2335400", "ProgramServices": "2084201", "ManagementAndGeneral": "251199"}, {"Description": "Consultants/Subcontract", "Total": "706261", "ProgramServices": "448707", "ManagementAndGeneral": "257554"}, {"Description": "REPAIRS & MAINTENANCE", "Total": "508809", "ProgramServices": "145427", "ManagementAndGeneral": "363382"}, {"Description": "MISCELLANEOUS", "Total": "76417", "ProgramServices": "2140", "ManagementAndGeneral": "74277"}, {"Description": "TELEPHONE", "Total": "61773", "ManagementAndGeneral": "61773"}], "TotalFunctionalExpenses": {"Total": "16323151", "ProgramServices": "8184126", "ManagementAndGeneral": "8139025", "Fundraising": "0"}, "CashNonInterestBearing": {"BOY": "2553688", "EOY": "49744"}, "AccountsReceivable": {"BOY": "2444034", "EOY": "1671875"}, "PrepaidExpensesDeferredCharges": {"BOY": "49533", "EOY": "48566"}, "LandBuildingsEquipmentBasisNet": {"BOY": "2123612", "EOY": "5486748"}, "InvestmentsPubTradedSecurities": {"BOY": "634219"}, "InvestmentsOtherSecurities": {"EOY": "1700000"}, "OtherAssetsTotal": {"BOY": "425970", "EOY": "2787686"}, "TotalAssets": {"BOY": "8231056", "EOY": "11744619"}, "AccountsPayableAccruedExpenses": {"BOY": "829037", "EOY": "4148593"}, "DeferredRevenue": {"BOY": "1804578", "EOY": "643539"}, "MortNotesPyblSecuredInvestProp": {"BOY": "828482", "EOY": "6739045"}, "OtherLiabilities": {"BOY": "350632", "EOY": "128376"}, "TotalLiabilities": {"BOY": "3812729", "EOY": "11659553"}, "UnrestrictedNetAssets": {"BOY": "-877676", "EOY": "-5645397"}, "TemporarilyRestrictedNetAssets": {"BOY": "2256083", "EOY": "2196809"}, "PermanentlyRestrictedNetAssets": {"BOY": "3039920", "EOY": "3533654"}, "TotalNetAssetsFundBalances": {"BOY": "4418327", "EOY": "85066"}, "TotalLiabNetAssetsFundBalances": {"BOY": "8231056", "EOY": "11744619"}, "NameOfPrincipalOfficerPerson": "PAUL J DAVIS MD", "GrossReceipts": "14136246", "GroupReturnForAffiliates": "0", "Organization501c@typeOf501cOrganization": "3", "Organization501c": "X", "WebSite": "www.ordwayresearch.org", "TypeOfOrganizationCorporation": "X", "YearFormation": "2002", "StateLegalDomicile": "NY", "ActivityOrMissionDescription": "TO TRANSLATE BASIC SCIENCE OBSERVATIONS INTO THERAPEUTICS IN SPECIFIC RESEARCH THEMES.", "NbrVotingMembersGoverningBody": "9", "NbrIndependentVotingMembers": "8", "TotalNbrEmployees": "112", "TotalNbrVolunteers": "21", "TotalGrossUBI": "0", "NetUnrelatedBusinessTxblIncome": "0", "ContributionsGrantsPriorYear": "17400958", "ContributionsGrantsCurrentYear": "12572168", "ProgramServiceRevenuePriorYear": "143519", "ProgramServiceRevenueCY": "642862", "InvestmentIncomePriorYear": "49916", "InvestmentIncomeCurrentYear": "-75035", "OtherRevenueCurrentYear": "0", "TotalRevenuePriorYear": "17594393", "TotalRevenueCurrentYear": "13139995", "GrantsAndSimilarAmntsCY": "0", "BenefitsPaidToMembersCY": "0", "SalariesEtcPriorYear": "7369666", "SalariesEtcCurrentYear": "7839216", "TotalProfFundrsngExpCY": "0", "TotalFundrsngExpCurrentYear": "0", "OtherExpensePriorYear": "7420367", "OtherExpensesCurrentYear": "8483935", "TotalExpensesPriorYear": "14790033", "TotalExpensesCurrentYear": "16323151", "RevenuesLessExpensesPriorYear": "2804360", "RevenuesLessExpensesCY": "-3183156", "TotalAssetsBOY": "8231056", "TotalAssetsEOY": "11744619", "TotalLiabilitiesBOY": "3812729", "TotalLiabilitiesEOY": "11659553", "NetAssetsOrFundBalancesBOY": "4418327", "NetAssetsOrFundBalancesEOY": "85066", "MissionDescription": "TO TRANSLATE BASIC SCIENCE OBSERVATIONS INTO THERAPEUTICS IN SPECIFIC RESEARCH THEMES.", "SignificantNewProgramServices": "0", "SignificantChange": "0", "Expense": "4191330", "Revenue": "642862", "Description": "BACTERIAL AND FUNGAL EMERGING INFECTIONS AND PHARMACODYNAMICS LABORATORY IS NATIONALLY AND INTERNATIONALLY RECOGNIZED FOR ITS WORK IN APPLYING CUTTING-EDGE RESEARCH TECHNIQUES TO DESIGN DOSING STRATEGIES FOR ANTIBIOTICS THAT OPTIMIZE THEIR EFFICACIES. MUCH OF THE LABORATORY'S WORK INVOLVES ANTIBACTERIAL AND ANTIFUNGAL DRUGS FOR THE TREATMENT OF HOSPITAL-ACQUIRED INFECTIONS.", "TotalOfOtherProgramServiceExp": "676459", "TotalProgramServiceExpense": "8184126", "DescribedIn501C3@referenceDocumentId": "RetDoc1039100001", "DescribedIn501C3": "1", "ScheduleBRequired@referenceDocumentId": "RetDoc1234500001", "ScheduleBRequired": "1", "PoliticalActivities@referenceDocumentId": "RetDoc1039700001", "PoliticalActivities": "0", "LobbyingActivities@referenceDocumentId": "RetDoc1039700001", "LobbyingActivities": "0", "DonorAdvisedFunds@referenceDocumentId": "RetDoc1040000001", "DonorAdvisedFunds": "0", "ConservationEasements@referenceDocumentId": "RetDoc1040000001", "ConservationEasements": "0", "CollectionsOfArt@referenceDocumentId": "RetDoc1040000001", "CollectionsOfArt": "0", "CreditCounseling@referenceDocumentId": "RetDoc1040000001", "CreditCounseling": "0", "TermOrPermanentEndowments@referenceDocumentId": "RetDoc1040000001", "TermOrPermanentEndowments": "1", "BalanceSheetAmountsReported@referenceDocumentId": "RetDoc1040000001", "BalanceSheetAmountsReported": "1", "IndependentAuditFinancialStmt@referenceDocumentId": "RetDoc1040000001", "IndependentAuditFinancialStmt": "1", "ConsolidatedAuditFinancialStmt@referenceDocumentId": "RetDoc1040000001", "ConsolidatedAuditFinancialStmt": "0", "School": "0", "ForeignOffice": "0", "ForeignActivities": "0", "MoreThan5000KToOrganizations": "0", "MoreThan5000KToIndividuals": "0", "ProfessionalFundraising": "0", "FundraisingActivities": "0", "Gaming": "0", "Hospital": "0", "GrantsToOrganizations": "0", "GrantsToIndividuals": "0", "ScheduleJRequired@referenceDocumentId": "RetDoc1042400001", "ScheduleJRequired": "1", "TaxExemptBonds": "0", "ExcessBenefitTransaction@referenceDocumentId": "RetDoc1042800001", "ExcessBenefitTransaction": "0", "PriorExcessBenefitTransaction@referenceDocumentId": "RetDoc1042800001", "PriorExcessBenefitTransaction": "0", "LoanToOfficerOrDQP@referenceDocumentId": "RetDoc1042800001", "LoanToOfficerOrDQP": "0", "GrantToRelatedPerson@referenceDocumentId": "RetDoc1042800001", "GrantToRelatedPerson": "0", "BsnssRltnshpWithOrganization@referenceDocumentId": "RetDoc1042800001", "BsnssRltnshpWithOrganization": "0", "BsnssRltnshpThruFamilyMember@referenceDocumentId": "RetDoc1042800001", "BsnssRltnshpThruFamilyMember": "0", "OfficerEntityWithBsnssRltnshp@referenceDocumentId": "RetDoc1042800001", "OfficerEntityWithBsnssRltnshp": "1", "DeductibleNonCashContributions@referenceDocumentId": "RetDoc1042900001", "DeductibleNonCashContributions": "1", "DeductibleContributionsOfArt@referenceDocumentId": "RetDoc1042900001", "DeductibleContributionsOfArt": "0", "Terminated": "0", "PartialLiquidation": "0", "DisregardedEntity@referenceDocumentId": "RetDoc1043400001", "DisregardedEntity": "1", "RelatedEntity@referenceDocumentId": "RetDoc1043400001", "RelatedEntity": "0", "RelatedOrgControlledEntity@referenceDocumentId": "RetDoc1043400001", "RelatedOrgControlledEntity": "0", "TransfersToExemptNonChrtblOrg@referenceDocumentId": "RetDoc1043400001", "TransfersToExemptNonChrtblOrg": "0", "ActivitiesConductedPartnership@referenceDocumentId": "RetDoc1043400001", "ActivitiesConductedPartnership": "0", "ScheduleORequired": "1", "NumberFormsTransmittedWith1096": "0", "NumberW2GIncluded": "0", "NumberOfEmployees": "112", "EmploymentTaxReturnsFiled": "1", "UnrelatedBusinessIncome": "0", "ForeignFinancialAccount": "0", "ProhibitedTaxShelterTrans": "0", "TaxablePartyNotification": "0", "NonDeductibleContributions": "0", "QuidProQuoContributions": "0", "Form8282PropertyDisposedOf": "0", "NbrVotingGoverningBodyMembers": "9", "NumberIndependentVotingMembers": "8", "FamilyOrBusinessRelationship": "0", "DelegationOfManagementDuties": "0", "ChangesToOrganizingDocs": "0", "MaterialDiversionOrMisuse": "0", "MembersOrStockholders": "0", "ElectionOfBoardMembers": "0", "DecisionsSubjectToApproval": "0", "MinutesOfGoverningBody": "1", "MinutesOfCommittees": "1", "OfficerMailingAddress": "0", "LocalChapters": "0", "Form990ProvidedToGoverningBody": "0", "ConflictOfInterestPolicy": "1", "AnnualDisclosureCoveredPersons": "1", "RegularMonitoringEnforcement": "1", "WhistleblowerPolicy": "1", "DocumentRetentionPolicy": "0", "CompensationProcessCEO": "1", "CompensationProcessOther": "1", "InvestmentInJointVenture": "0", "StatesWhereCopyOfReturnIsFiled": "NY", "UponRequest": "X", "TotalReportableCompFromOrg": "1722582", "TotalReportableCompFrmRltdOrgs": "0", "TotalOtherCompensation": "144175", "NumberIndividualsGT100K": "8", "FormersListed": "0", "TotalCompGT150K": "1", "CompensationFromOtherSources": "0", "NumberOfContractorsGT100K": "0", "AllOtherContributions": "12572168", "TotalContributions": "12572168", "TotalProgramServiceRevenue": "642862", "LandBuildingsEquipmentBasis": "7418099", "LandBldgEquipmentAccumDeprec": "1931351", "FollowSFAS117": "X", "MethodOfAccountingAccrual": "X", "AccountantCompileOrReview": "0", "FSAudited": "1", "AuditCommittee": "1", "FinancialStatementSeparate": "X", "FederalGrantAuditRequired": "1", "FederalGrantAuditPerformed": "1"}, "IRS990ScheduleA": {"HospitalNameAndAddress": {"Name": {"BusinessNameLine1": "ALBANY MEDICAL CENTER"}, "City": "ALBANY", "State": "NY"}, "MedicalResearchOrg170b1Aiii": "X"}, "IRS990ScheduleB": {"ContributorInfo": {"ContributorNameBusiness": {"BusinessNameLine1": "RESTRICTED"}, "ContributorAddressUS": {"AddressLine1": "RESTRICTED", "AddressLine2": "RESTRICTED", "City": "RESTRICTED", "State": "RESTRICTED", "ZIPCode": "RESTRICTED"}, "ContributorNumber": "RESTRICTED", "AggregateContributions": "RESTRICTED"}}, "IRS990ScheduleC": {"Form990ScheduleCPartIV": {"Identifier": "Part II-B, Line 1i:", "ReturnReference": "Explanation of Other Lobbying Activities:", "Explanation": "ORDWAY RESEARCH INSTITUTE IS A MEMBER OF THE ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES (AIRI). FIFTEEN PERCENT (15%) OF THE ANNUAL MEMBERSHIP DUES APPLY TO AIRI LOBBYING EXPENSES. THE AIRI LOBBYING EFFORTS ADDRESS ISSUES RELATED TO CONGRESSIONAL DECISIONS IN REGARD TO THE DIRECT FUNDING OF THE NATIONAL INSTITUTE OF HEALTH."}, "OtherActivities": "1", "OtherActivitiesAmount": "180", "TotalLobbyingExpendituresIIB": "180", "NotDescribedIn501c3": "0"}, "IRS990ScheduleD": {"CurrentYear": {"BeginningOfYearBalance": "2954041", "Contributions": "500000", "InvestmentEarningsOrLosses": "-6266", "EndOfYearBalance": "3447775"}, "CurrentYearMinus1Year": {"BeginningOfYearBalance": "2000000", "Contributions": "1000000", "InvestmentEarningsOrLosses": "-45959", "EndOfYearBalance": "2954041"}, "Land": {"OtherCostOrOtherBasis": "1200000", "BookValue": "1200000"}, "Buildings": {"OtherCostOrOtherBasis": "319193", "BookValue": "319193"}, "Equipment": {"OtherCostOrOtherBasis": "5898906", "Depreciation": "1931351", "BookValue": "3967555"}, "OtherSecurities": {"Description": "PRIVATE EQUITY SECURITIES", "BookValue": "1700000", "MethodOfValuation": "C"}, "OtherAssets": [{"Description": "Patent Costs", "BookValue": "2775539"}, {"Description": "SECURITY DEPOSITS", "BookValue": "12147"}], "OtherLiabilities": {"Description": "Accrued personal leave", "Amount": "128376"}, "Form990ScheduleDPartXIV": [{"Identifier": "Part V, Line 4:", "ReturnReference": "Description of Intended Use of Endowment Funds:", "Explanation": "THE ENDOWMENT IS A PERMANENT ENDOWMENT. 50% OF THE INCOME IS INTENDED TO SUPPORT RESEARCH EFFORTS AND 50% OF THE INCOME IS INTENDED TO INCREASE THE ENDOWMENT CORPUS."}, {"Identifier": "Part X:", "ReturnReference": "Description of Uncertain Tax Positions Under FIN 48:", "Explanation": "The Institute is a not-for-profit organization as described in Section 501(c)(3) of the Internal Revenue Code and is exempt from federal income taxes pursuant to Section 501(a)(2) of the Internal Revenue Code. The Institute has been classified as a publicly supported organization, which is not a private foundation under Section 509(a) of the Code. When income tax returns are filed, some tax positions taken are highly certain to be sustained upon examination by the taxing authorities, while other tax positions are subject to uncertainty about the technical merits of the position or the amount of the position's tax benefit that would be ultimately sustained. The benefit of an uncertain tax position may be recognized in the financial statements only if it is more likely than not that the tax position will be sustained, based on its technical merits, upon examination, including the resolution of appeals or litigation processes, if any. The amount of the tax benefit recognized is measured as the largest amount that is determined to have a greater than 50% likelihood of being realized upon ultimate settlement. The portion of the benefits associated with tax positions taken that exceeds the amount measured as previously described is reflected as a liability for unrecognized tax benefits in the accompanying statement of financial position and includes, where applicable, accrued interest and/or penalties attributable to the unrecognized tax benefits. Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of activities. Forms 990 filed by the Institute are subject to examination by the Internal Revenue Service up to three years from the extended due date of each return. Form 990 filed by the Institute is no longer subject to examination for the fiscal years ended June 30, 2006, and prior."}, {"Identifier": "Part XII, Line 4b - Other Adjustments:", "Explanation": "LOSS ON DISPOSAL OF FIXED ASSETS: -237490."}, {"Identifier": "Part XIII, Line 2d - Other Adjustments:", "Explanation": "LOSS ON DISPOSAL OF FIXED ASSETS: 237490."}], "PermanentEndowmentEOYBalance": "1.00000", "EndowmentsHeldByUnrelatedOrgs": "0", "EndowmentsHeldByRelatedOrgs": "0", "TotalOfBookValueLandBuildings": "5486748", "TotalOfBookValueSecurities": "1700000", "TotalBookValueOtherAssets": "2787686", "TotalOfAmounts": "128376", "TotalRevenue": "13139995", "TotalExpenses": "16323151", "ExcessOrDeficitForYear": "-3183156", "PriorPeriodAdjustments": "-1150105", "TotalAdjustments": "-1150105", "ExcessOrDeficitPerFS": "-4333261", "TotRevenueEtcAuditedFinclStmt": "13377485", "RevenueNotRptdF990": "0", "RevenueSubtotal": "13377485", "OtherRevenuesNotIncluded": "-237490", "RevenueNotRptdOnFinStmt": "-237490", "TotalRevenuePerForm990": "13139995", "TotExpensesEtcAuditedFinclStmt": "16560641", "OtherExpensesIncluded": "237490", "ExpensesNotRptdF990": "237490", "ExpensesSubtotal": "16323151", "ExpensesNotRptdOnFinStmt": "0", "TotalExpensesPerForm990": "16323151"}, "IRS990ScheduleJ": {"Form990ScheduleJPartII": [{"NameBusiness": {"BusinessNameLine1": "PAUL DAVIS MD"}, "BaseCompensationFilingOrg": "293657", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "15881", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "3759", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "313297", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "GEORGE DRUSANO"}, "BaseCompensationFilingOrg": "326618", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "13440", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "4055", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "344113", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "IGOR RONINSON"}, "BaseCompensationFilingOrg": "231886", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "13087", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "9902", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "254875", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "ARNOLD LOUIE"}, "BaseCompensationFilingOrg": "245719", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "14604", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "975", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "261298", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "paul ambrose"}, "BaseCompensationFilingOrg": "187991", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "16500", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "6581", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "211072", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "RAlph buttyan"}, "BaseCompensationFilingOrg": "176845", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "10813", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "5753", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "193411", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}, {"NameBusiness": {"BusinessNameLine1": "SUJATA BHAVNANI"}, "BaseCompensationFilingOrg": "150050", "CompBasedOnRelatedOrgs": "0", "BonusFilingOrg": "0", "BonusRelatedOrgs": "0", "OtherCompensationFilingOrg": "0", "OtherCompensationRelatedOrgs": "0", "DeferredCompFilingOrg": "16500", "DeferredCompRelatedOrgs": "0", "NontaxableBenefitsFilingOrg": "4281", "NontaxableBenefitsRelatedOrgs": "0", "TotalCompensationFilingOrg": "170831", "TotalCompensationRelatedOrgs": "0", "CompReportPrior990FilingOrg": "0", "CompReportPrior990RelatedOrgs": "0"}], "DiscretionarySpendingAccount": "X", "WrittenPolicyReTAndEExpenses": "1", "SubstantiationRequired": "1", "WrittenEmploymentContract": "X", "CompensationSurvey": "X", "BoardOrCommitteeApproval": "X", "SeverancePayment": "0", "SupplementalNonqualRetirePlan": "0", "EquityBasedCompArrangement": "0", "CompBasedOnRevenueOfFilingOrg": "0", "CompBasedOnRevenueRelatedOrgs": "0", "CompBasedNetEarningsFilingOrg": "0", "CompBasedNetEarningsRelateOrgs": "0", "AnyNonFixedPayments": "0", "InitialContractException": "0"}, "IRS990ScheduleL": {"Form990ScheduleLPartIV": {"NameOfInterestedPerson": {"NamePerson": "RICHARD LEIBICH"}, "Relationship": "TREASURER", "AmountOfTransaction": "3302738", "DescriptionOfTransaction": "THIS BOARD MEMBER IS THE PRESIDENT OF THE CENTER FOR MEDICAL SCIENCE, A NON-PROFIT ORGANIZATION, WHICH LEASES SPACE AT 150 NEW SCOTLAND AVENUE TO ORDWAY INSTITUTE.", "SharingOfRevenues": "0"}}, "IRS990ScheduleM": {"SecuritiesPubliclyTraded": {"NonCashCheckbox": "X", "NumberOfContributions": "1", "NoncashContribsRptdF990": "37135", "MethodOfDeterminingRevenues": "FAIR MARKET VALUE"}, "AnyPropertyThatMustBeHeld": "0", "ReviewProcessUnusualNCGifts": "0", "ThirdPartiesUsed": "0"}, "IRS990ScheduleO": {"GeneralExplanation": [{"Identifier": "Form 990, Part VI, Section B, line 11", "Explanation": "THE AUDITED FINANCIAL STATEMENTS ARE PRESENTED TO THE BOARD. THE 990 IS REVIEWED AND APPROVED BY CORPORATE SECRETARY ALBERT SZESNAT."}, {"Identifier": "Form 990, Part VI, Section B, line 12c", "Explanation": "CONFLICT OF INTEREST POLICY MONITORING"}, {"Identifier": "Form 990, Part VI, Section B, line 15", "Explanation": "CONTRACT NEGOTIATIONS ARE HELD AMONG THE EXECUTIVE DIRECTOR, CHAIRMAN OF THE BOARD AND THE EMPLOYEE. ORDWAY HAS A SALARY ADMINISTRATION PROGRAM THAT LOOKS AT SIMILAR POSITIONS AT SIMILAR INDUSTRIES AND AT THE ANNUAL SURVEY OF THE ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES. THE BOARD APPROVES THE EXECUTIVE DIRECTOR'S SALARY."}, {"Identifier": "Form 990, Part VI, Section C, line 19", "Explanation": "THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON WRITTEN REQUEST."}, {"Identifier": "FORM 990, PART XI, LINE 2C:", "Explanation": "the process of selecting an independent accountant and of reviewing the financial statements has not changed from the prior year."}, {"Explanation": "SCHEDULE R, PART 1, AS OF AUGUST 10, 2010 THE ORGANIZATION IN A SPIN-OFF FROM ORDWAY FORMED A C-CORPORATION. ORDWAY HAS A 39% EQUITY POSITION IN THE NEW CORPORATION. THIS WAS A SUBSEQUENT EVENT OCCURRING AFTER JUNE 30, 2010."}]}, "IRS990ScheduleR": {"Form990ScheduleRPartI": {"NameOfDisregardedEntity": {"BusinessNameLine1": "INSTITUTE FOR CLINICAL PHARMACODYNAMICS AND DESIGN"}, "AddressUS": {"AddressLine1": "43 BRITISH-AMERICAN BLVD", "City": "LATHAM", "State": "NY", "ZIPCode": "12211"}, "DirectControllingEntityName": {"BusinessNameLine1": "ORDWAY RESEARCH INSTITUTE INC"}, "EIN": "010682614", "PrimaryActivities": "RESEARCH", "LegalDomicileState": "NY"}}, "IRS990@documentId": "RetDoc1038000001", "IRS990@referenceDocumentId": "RetDoc1044400001", "IRS990ScheduleA@documentId": "RetDoc1039100001", "IRS990ScheduleB@documentId": "RetDoc1234500001", "IRS990ScheduleC@documentId": "RetDoc1039700001", "IRS990ScheduleD@documentId": "RetDoc1040000001", "IRS990ScheduleJ@documentId": "RetDoc1042400001", "IRS990ScheduleL@documentId": "RetDoc1042800001", "IRS990ScheduleM@documentId": "RetDoc1042900001", "IRS990ScheduleO@documentId": "RetDoc1044400001", "IRS990ScheduleR@documentId": "RetDoc1043400001"}, "ReturnHeader@binaryAttachmentCount": "0", "ReturnData@documentCount": "10"}, "Return@returnVersion": "2009v1.7"}